Halper Sadeh LLC Investigates ACA, TECH, IRDM, LCII Deals for Shareholder Fairness

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed acquisitions of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are fair to shareholders. The firm is examining Arcosa's sale to CRH for $150.00 per share, Bio-Techne's sale to Merck KGaA for $73.00 per share in cash, Iridium's sale to Rocket Lab for $27.00 in cash plus Rocket Lab shares, and LCI Industries' sale to Patrick Industries for 1.2440 shares of Patrick common stock per LCI share. Halper Sadeh may seek increased consideration or additional disclosures on behalf of shareholders, and encourages them to contact the firm at no cost to discuss their legal rights and options.

Impact on stocks 4

Energy Transition & Power Demand▲ · 1 stocks
Arcosa Inc
ACA
± MixedCapitalrelevance

Investigation into fairness of Arcosa's sale to CRH at $150/share may lead to increased consideration or disclosures.

Space Economy▲ · 1 stocks
Iridium Communications Inc
IRDM
± MixedCapitalrelevance

Investigation into fairness of Iridium's sale to Rocket Lab for cash and shares may lead to improved terms.

Consumer Discretionary▲ · 1 stocks
LCI Industries
LCII
± MixedCapitalrelevance

Investigation into fairness of LCI Industries' sale to Patrick Industries for stock may lead to increased consideration.

Biotech & Genomic Medicine▲ · 1 stocks
Bio-Techne Corp
TECH
± MixedCapitalrelevance

Investigation into fairness of Bio-Techne's sale to Merck KGaA at $73/share may lead to improved terms.

© 2026 MarketDXNews